Related Experiment Video
Updated: Jun 19, 2026

Large-Scale Multi-Omics Genome-Wide Association Studies (Mo-GWAS): Guidelines for Sample Preparation and Normalization
Published on: July 27, 2021
Personalized polygenic profiling based on the genetic architecture of lipid metabolism in the Russian population
Aleksandra Mamchur1, Maria Bruttan1, Veronika Daniel1
1Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks» of the Federal Medical and Biological Agency (Centre for Strategic Planning, of the Federal Medical and Biological Agency), Moscow, Russia.
Objective:
Elevated cholesterol levels are associated with the risk of the most socially significant cardiovascular diseases, such as atherosclerosis, ischemic heart disease, and myocardial infarction.
Methods:
In this study, we sought to study the genetic architecture of lipid metabolism by conducting genome-wide association studies of total cholesterol, LDL-C, and HDL-C levels in a sample of the Russian population (n = 8,732) who were not carriers of variants linked to familial hypercholesterolemia and did not take lipid-regulating agents. Based on the detected associations and machine learning methods, several polygenic score models were constructed for each lipid type, and the link between polygenic scores and atherosclerosis, ischemic heart disease, and myocardial infarction was examined in an additional sample of patients diagnosed with either of these diseases (n = 3,954).
Results:
A meta-analysis of the results of the conducted genome-wide association studies showed that total cholesterol and LDL-C were largely associated with the same variants located in the HMGCR, CERT1, POLK, ANKDD1B, APOC3, BCL3, CBLC, BCAM, NECTIN2, TOMM40, APOE, APOC1, APOC4, and SMARCA4 genes, while HDL-C was associated with variants located in the LPL, ALDH1A2, LIPC, and CETP genes. Men and women differed in genetic predictors of lipid levels, with variants in the SMARCA4 and LDLR genes associated with cholesterol levels only in women.
Conclusion:
The models developed in this study consider age and a modifiable factor, BMI. Therefore, the personalized polygenic profiling approach presented in this study enables life-long CVD risk assessment.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenetics of Drug Metabolism: Overview
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
Principles of Pharmacogenetics: Types of Genetic Variants
